🔎 Trials Near Me

Utama › Migrain › Tennessee

Kajian klinikal Migrain di Tennessee

8 kajian untuk Migrain sedang mencari peserta di lokasi di Tennessee.

Bandar di Tennessee

Teks kajian rasmi (Bahasa Inggeris)

Study of EVO756 in Adults With Migraine

  • Campbell Clinical Research, Franklin
Mengambil pesertaFasa 2
Umur 18 hingga 64 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07616128

MMA Embolization for Refractory Chronic Migraine

  • Semmes Murphey Foundation, Memphis
Mengambil peserta
Umur 18 hingga 65 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06735833

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  • Access Clinical Trials Inc /ID# 270280, Nashville
Mengambil pesertaFasa 3
Umur 12 hingga 17 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06810505

Responding With Evidence and Access for Childhood Headaches

  • University of Tennessee Health Science Center/ LeBonheur Children's Hospital, Memphis
Mengambil peserta
Umur 10 hingga 17 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05889624

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • Vanderbilt Medical Center, Nashville
Mengambil pesertaFasa 4
Umur 18 hingga 70 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Access Clinical Trials, Inc. /ID# 228002, Nashville
Mengambil pesertaFasa 3
Umur 6 hingga 17 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • WR-ClinSearch, LLC, Chattanooga
  • Access Clinical Trials, Inc, Nashville
  • Clinical Research Associates, Inc., Nashville
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07645924

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.